Pamela A. Davol
- Oncology top 10%
- CAR-T cell therapy research 10
- HER2/EGFR in Cancer Research 4
-
- Immunotherapy and Immune Responses 4
- Toxin Mechanisms and Immunotoxins 4
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- Mesenchymal stem cell research 3
-
- Proteoglycans and glycosaminoglycans research 5
-
- Fibroblast Growth Factor Research 3
- Co-authors
- Lawrence G. LumA. Raymond FrackeltonJonathan M. GallGerald J. ElfenbeinRandall J. LeeAbby MaizelNicola KouttabJames B. Davis
- Partner nations
- United StatesPolandCanada
In The Last Decade
Pamela A. Davol
24 papers receiving 538 citations
Peers
Comparison fields: 5 of 52
- Oncology 282
- Immunology 196
- Radiology, Nuclear Medicine and Imaging 195
- Genetics 60
- Biotechnology 29
Countries citing papers authored by Pamela A. Davol
This map shows the geographic impact of Pamela A. Davol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela A. Davol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela A. Davol more than expected).
Fields of papers citing papers by Pamela A. Davol
This network shows the impact of papers produced by Pamela A. Davol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela A. Davol. The network helps show where Pamela A. Davol may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pamela A. Davol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 23 | |
| 2 | 2006 | 63 | |
| 3 | 2006 | 25 | |
| 4 | 2006 | 19 | |
| 5 | 2006 | 74 | |
| 6 | Preclinical studies comparing different bispecific antibodies for redirecting T cell cytotoxicity to extracellular antigens on prostate carcinomas. | 2005 | 14 |
| 7 | 2005 | 50 | |
| 8 | 2005 | 19 | |
| 9 | 2005 | 4 | |
| 10 | 2004 | 2 | |
| 11 | 2004 | 29 | |
| 12 | 2004 | 24 | |
| 13 | Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer. | 2003 | 56 |
| 14 | 1999 | 24 | |
| 15 | 1999 | 1 | |
| 16 | 1999 | 11 | |
| 17 | 1997 | 7 | |
| 18 | 1996 | 1 | |
| 19 | 1995 | 9 | |
| 20 | 1995 | 10 |
About Pamela A. Davol
Pamela A. Davol is a scholar working on Oncology, Immunology and Genetics, having authored 24 papers that have together received 558 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Proteoglycans and glycosaminoglycans research (5 papers), Immunotherapy and Immune Responses (4 papers), HER2/EGFR in Cancer Research (4 papers), Toxin Mechanisms and Immunotoxins (4 papers), Fibroblast Growth Factor Research (3 papers) and Mesenchymal stem cell research (3 papers). The work is most often cited by research in Oncology (282 citations), Immunology (196 citations) and Radiology, Nuclear Medicine and Imaging (195 citations). Pamela A. Davol has collaborated with scholars based in United States, Poland and Canada. Frequent co-authors include Lawrence G. Lum, A. Raymond Frackelton, Jonathan M. Gall, Gerald J. Elfenbein, Randall J. Lee, Abby Maizel, Nicola Kouttab, James B. Davis, James F. Padbury and Wendy B. Young. Their work appears in journals such as Blood, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.